Genomic Association Analysis Suggests Chromosome 12 Locus Influencing Antihypertensive Response to Thiazide Diuretic
We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nu...
Saved in:
| Published in | Hypertension (Dallas, Tex. 1979) Vol. 52; no. 2; pp. 359 - 365 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Philadelphia, PA
American Heart Association, Inc
01.08.2008
Hagerstown, MD Lippincott |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0194-911X 1524-4563 1524-4563 |
| DOI | 10.1161/HYPERTENSIONAHA.107.104273 |
Cover
| Abstract | We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 “good” responders (diastolic BP response [mean±SD]=−18.3±4.2 mm Hg; age=47.1±6.1 years; 51.5% women) and 97 “poor” responders (diastolic BP response=−0.18±4.3; age=47.4±6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme (LYZ), YEATS domain containing 4 (YEATS4), and fibroblast growth receptor substrate 2 (FRS2) were significantly associated with diastolic BP response (nominal P=2.39×10; Bonferroni corrected P=0.024; simulated experiment-wise P=0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to “tag” linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses. |
|---|---|
| AbstractList | We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 "good" responders (diastolic BP response [mean plus or minus SD]=-18.3 plus or minus 4.2 mm Hg; age=47.1 plus or minus 6.1 years; 51.5% women) and 97 "poor" responders (diastolic BP response=-0.18 plus or minus 4.3; age=47.4 plus or minus 6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme (LYZ), YEATS domain containing 4 (YEATS4), and fibroblast growth receptor substrate 2 (FRS2) were significantly associated with diastolic BP response (nominal P=2.39x10 super(-7); Bonferroni corrected P=0.024; simulated experiment-wise P=0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to "tag" linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses. We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 “good” responders (diastolic BP response [mean±SD]=−18.3±4.2 mm Hg; age=47.1±6.1 years; 51.5% women) and 97 “poor” responders (diastolic BP response=−0.18±4.3; age=47.4±6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme ( LYZ ), YEATS domain containing 4 ( YEATS4 ), and fibroblast growth receptor substrate 2 ( FRS2 ) were significantly associated with diastolic BP response (nominal P =2.39×10 −7 ; Bonferroni corrected P =0.024; simulated experiment-wise P =0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to “tag” linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses. We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 “good” responders (diastolic BP response [mean±SD]=−18.3±4.2 mm Hg; age=47.1±6.1 years; 51.5% women) and 97 “poor” responders (diastolic BP response=−0.18±4.3; age=47.4±6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme (LYZ), YEATS domain containing 4 (YEATS4), and fibroblast growth receptor substrate 2 (FRS2) were significantly associated with diastolic BP response (nominal P=2.39×10; Bonferroni corrected P=0.024; simulated experiment-wise P=0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to “tag” linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses. We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 "good" responders (diastolic BP response [mean+/-SD]=-18.3+/-4.2 mm Hg; age=47.1+/-6.1 years; 51.5% women) and 97 "poor" responders (diastolic BP response=-0.18+/-4.3; age=47.4+/-6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme (LYZ), YEATS domain containing 4 (YEATS4), and fibroblast growth receptor substrate 2 (FRS2) were significantly associated with diastolic BP response (nominal P=2.39 x 10(-7); Bonferroni corrected P=0.024; simulated experiment-wise P=0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to "tag" linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses. We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 “good” responders (diastolic BP response [mean±SD]=-18.3±4.2 mm Hg; age=47.1±6.1 years; 51.5% women) and 97 “poor” responders (diastolic BP response=-0.18±4.3; age=47.4±6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme ( LYZ ), YEATS domain containing 4 ( YEATS4 ), and fibroblast growth receptor substrate 2 ( FRS2 ) were significantly associated with diastolic BP response (nominal P =2.39×10 -7 ; Bonferroni corrected P =0.024; simulated experiment-wise P =0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to “tag” linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses. We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 "good" responders (diastolic BP response [mean+/-SD]=-18.3+/-4.2 mm Hg; age=47.1+/-6.1 years; 51.5% women) and 97 "poor" responders (diastolic BP response=-0.18+/-4.3; age=47.4+/-6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme (LYZ), YEATS domain containing 4 (YEATS4), and fibroblast growth receptor substrate 2 (FRS2) were significantly associated with diastolic BP response (nominal P=2.39 x 10(-7); Bonferroni corrected P=0.024; simulated experiment-wise P=0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to "tag" linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses.We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly prescribed thiazide diuretic preferred for the treatment of high BP. Affymetrix GeneChip Human Mapping 100K Arrays were used to measure single nucleotide polymorphisms across the 22 autosomes in 194 non-Hispanic black subjects and 195 non-Hispanic white subjects with essential hypertension selected from opposite tertiles of the race- and sex-specific distributions of age-adjusted diastolic BP response to hydrochlorothiazide (25 mg daily, PO, for 4 weeks). The black sample consisted of 97 "good" responders (diastolic BP response [mean+/-SD]=-18.3+/-4.2 mm Hg; age=47.1+/-6.1 years; 51.5% women) and 97 "poor" responders (diastolic BP response=-0.18+/-4.3; age=47.4+/-6.5 years; 51.5% women). Haplotype trend regression identified a region of chromosome 12q15 in which haplotypes constructed from 3 successive single nucleotide polymorphisms (rs317689, rs315135, and rs7297610) in proximity to lysozyme (LYZ), YEATS domain containing 4 (YEATS4), and fibroblast growth receptor substrate 2 (FRS2) were significantly associated with diastolic BP response (nominal P=2.39 x 10(-7); Bonferroni corrected P=0.024; simulated experiment-wise P=0.040). Genotyping of 35 additional single nucleotide polymorphisms selected to "tag" linkage disequilibrium blocks in these genes provided corroboration that variation in LYZ and YEATS4 was associated with diastolic BP response in a statistically independent data set of 291 black subjects and in the sample of 294 white subjects. These results support the use of genome-wide association analyses to identify novel genes influencing antihypertensive drug responses. |
| Author | Kocher, Jean-Pierre Turner, Stephen T. Boerwinkle, Eric Bailey, Kent R. Chapman, Arlene B. Schwartz, Gary L. Fridley, Brooke L. Rodin, Andréi S. Chai, High Seng Sicotte, Hugues |
| AuthorAffiliation | From the Division of Nephrology and Hypertension (S.T.T., G.L.S.), Department of Medicine, and Divisions of Biostatistics (K.R.B., B.L.F.) and Biomedical Informatics (H.S.C., H.S., J.-P.K.), Department of Health Sciences Research, Mayo Clinic, College of Medicine, Rochester, Minn; the Renal Division (A.B.C.), Department of Medicine, Emory University, Atlanta, Ga; and the Human Genetics Center (A.S.R., E.B.), School of Public Health, University of Texas-Houston Health Science Center |
| AuthorAffiliation_xml | – name: From the Division of Nephrology and Hypertension (S.T.T., G.L.S.), Department of Medicine, and Divisions of Biostatistics (K.R.B., B.L.F.) and Biomedical Informatics (H.S.C., H.S., J.-P.K.), Department of Health Sciences Research, Mayo Clinic, College of Medicine, Rochester, Minn; the Renal Division (A.B.C.), Department of Medicine, Emory University, Atlanta, Ga; and the Human Genetics Center (A.S.R., E.B.), School of Public Health, University of Texas-Houston Health Science Center |
| Author_xml | – sequence: 1 givenname: Stephen surname: Turner middlename: T. fullname: Turner, Stephen T. organization: From the Division of Nephrology and Hypertension (S.T.T., G.L.S.), Department of Medicine, and Divisions of Biostatistics (K.R.B., B.L.F.) and Biomedical Informatics (H.S.C., H.S., J.-P.K.), Department of Health Sciences Research, Mayo Clinic, College of Medicine, Rochester, Minn; the Renal Division (A.B.C.), Department of Medicine, Emory University, Atlanta, Ga; and the Human Genetics Center (A.S.R., E.B.), School of Public Health, University of Texas-Houston Health Science Center – sequence: 2 givenname: Kent surname: Bailey middlename: R. fullname: Bailey, Kent R. – sequence: 3 givenname: Brooke surname: Fridley middlename: L. fullname: Fridley, Brooke L. – sequence: 4 givenname: Arlene surname: Chapman middlename: B. fullname: Chapman, Arlene B. – sequence: 5 givenname: Gary surname: Schwartz middlename: L. fullname: Schwartz, Gary L. – sequence: 6 givenname: High surname: Chai middlename: Seng fullname: Chai, High Seng – sequence: 7 givenname: Hugues surname: Sicotte fullname: Sicotte, Hugues – sequence: 8 givenname: Jean-Pierre surname: Kocher fullname: Kocher, Jean-Pierre – sequence: 9 givenname: Andréi surname: Rodin middlename: S. fullname: Rodin, Andréi S. – sequence: 10 givenname: Eric surname: Boerwinkle fullname: Boerwinkle, Eric |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20535818$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18591461$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkl1v0zAUhiM0xLrBX0AREtxl-Ct2zAWiKmWtVG1oKxJcWY5z2hgSu8TJpvLrMWupYDebrSNL9nNe-xy_J8mR8w6S5BVGZxhz_Hb27fP0ajm9uJ5fXoxn4zOMRAxGBH2SjHBOWMZyTo-SEcKSZRLjr8fJSQjfEcKMMfEsOcZFLjHjeJT05-B8a006DsEbq3vrXTp2utkGG9LrYb2G0Id0Une-9cG3kGKSLrwZQjp3q2YAZ6xbx4ze1tsNdD24YG8gvYKw8S5A2vt0WVv9y1aQfrRDB701z5OnK90EeLFfT5Mvn6bLySxbXJ7PJ-NFZriUNCsLbYDonEsNTOKSVaI0sCIFB0w4rnJUSSRIUaCVyAHKoopFiRxpWXJNKk5Pk_c73c1QtlAZcH2nG7XpbKu7rfLaqv9PnK3V2t8owiURGEWBN3uBzv8cYidUa4OBptEO_BAUlzRngjwMEiQpp1Q-CGJ5dzN5BCgwzYWI4Mt_izxU9_ePI_B6D-hgdLPqdPyzcOAIymle4CJyH3ac6XwIHayUsf2dIWJvbKMwUn_sp-7ZL-4LtbNflHh3T-Lwmscks13yrW966MKPZriFTtWgm75WKA5GeJERhIo4EcpiUEp_AxAF83Y |
| CODEN | HPRTDN |
| CitedBy_id | crossref_primary_10_1007_s12170_009_0065_0 crossref_primary_10_1016_j_coph_2016_01_005 crossref_primary_10_1097_HJH_0000000000000574 crossref_primary_10_1042_BSR20190296 crossref_primary_10_1097_MJT_0b013e3181e90863 crossref_primary_10_2217_pgs_11_110 crossref_primary_10_1186_1471_2105_10_102 crossref_primary_10_1186_1741_7015_11_141 crossref_primary_10_1007_s10741_018_09765_y crossref_primary_10_2217_pgs_11_115 crossref_primary_10_3389_fped_2017_00285 crossref_primary_10_34067_KID_0005362021 crossref_primary_10_2217_pgs_15_131 crossref_primary_10_1080_23808993_2018_1420419 crossref_primary_10_1038_hr_2012_82 crossref_primary_10_3390_jpm11060480 crossref_primary_10_1097_FPC_0000000000000353 crossref_primary_10_1097_HCO_0b013e32832c58ba crossref_primary_10_3390_jpm10040267 crossref_primary_10_1002_wsbm_1199 crossref_primary_10_2217_pgs_13_161 crossref_primary_10_1038_nbt_2424 crossref_primary_10_1371_journal_pone_0052062 crossref_primary_10_1038_tpj_2017_10 crossref_primary_10_1097_FPC_0b013e32833d7b45 crossref_primary_10_1038_tpj_2011_32 crossref_primary_10_1016_j_pharmthera_2017_02_036 crossref_primary_10_1161_CIRCULATIONAHA_109_914820 crossref_primary_10_1097_FPC_0000000000000361 crossref_primary_10_3390_ijms21134709 crossref_primary_10_1161_CIRCRESAHA_110_230995 crossref_primary_10_2217_pgs_09_61 crossref_primary_10_1038_nrg2751 crossref_primary_10_1097_FPC_0b013e32833b5958 crossref_primary_10_2217_pgs_13_231 crossref_primary_10_1007_s11906_010_0174_7 crossref_primary_10_1038_jhh_2015_121 crossref_primary_10_2217_14622416_10_2_161 crossref_primary_10_1038_clpt_2011_179 crossref_primary_10_1111_j_1365_2362_2011_02472_x crossref_primary_10_3390_ph3061779 crossref_primary_10_1161_HYP_0b013e31825b30f8 crossref_primary_10_1186_s40535_015_0013_7 crossref_primary_10_1038_clpt_2008_274 crossref_primary_10_1016_j_cjca_2012_02_004 crossref_primary_10_1586_ecp_12_58 crossref_primary_10_1124_pharmrev_123_000750 crossref_primary_10_1253_jjcsc_17_1_62 crossref_primary_10_1007_s11906_015_0586_5 crossref_primary_10_1016_j_yamp_2019_08_002 crossref_primary_10_1038_s41440_019_0356_x crossref_primary_10_1016_j_ijcard_2015_02_025 crossref_primary_10_1038_s41440_021_00825_9 crossref_primary_10_1002_cpt_1491 crossref_primary_10_2217_pgs_10_34 crossref_primary_10_1007_s40362_016_0038_x crossref_primary_10_1155_2023_9919677 crossref_primary_10_1053_j_ackd_2016_02_003 crossref_primary_10_1161_HYPERTENSIONAHA_112_192559 crossref_primary_10_1159_000367962 crossref_primary_10_1097_HJH_0000000000000541 crossref_primary_10_3390_jcm12051799 crossref_primary_10_3109_03602532_2015_1047027 crossref_primary_10_1038_nrneph_2015_176 crossref_primary_10_1016_j_biopsych_2009_08_029 crossref_primary_10_1038_tpj_2012_4 crossref_primary_10_1111_bph_17414 crossref_primary_10_1161_HYPERTENSIONAHA_116_08267 crossref_primary_10_2217_pme_09_55 crossref_primary_10_1016_j_jacc_2009_07_059 crossref_primary_10_1038_hr_2009_87 crossref_primary_10_3109_07853890_2011_653399 crossref_primary_10_1007_s11906_013_0388_6 crossref_primary_10_1038_jhh_2014_76 crossref_primary_10_1186_1744_8603_9_50 crossref_primary_10_1158_1078_0432_CCR_13_2755 crossref_primary_10_2217_pgs_11_76 crossref_primary_10_1161_JAHA_114_001521 |
| Cites_doi | 10.1001/jama.280.13.1168 10.1161/01.hyp.0000186240.81996.57 10.1126/science.1105436 10.1097/00004872-200102000-00022 10.1046/j.1523-1755.2002.00200.x 10.1161/hyp.34.3.466 10.1086/381000 10.1056/NEJM199304013281303 10.1161/01.hyp.12.3.223 10.1016/S0895-7061(03)01011-2 10.1073/pnas.0506580102 10.1101/gr.197201 10.1038/ng1847 10.1161/01.HYP.0000107251.49515.c2 10.1159/000057986 10.1111/j.1524-6175.2002.00965.x 10.1038/ng749 10.1086/338688 10.1016/S0140-6736(97)01029-5 10.1038/nature04226 10.1007/s00251-005-0025-x 10.1371/journal.pbio.0020427 10.1161/HYPERTENSIONAHA.107.087049 |
| ContentType | Journal Article |
| Copyright | 2008 American Heart Association, Inc. 2008 INIST-CNRS 2008 American Heart Association, Inc. 2008 |
| Copyright_xml | – notice: 2008 American Heart Association, Inc. – notice: 2008 INIST-CNRS – notice: 2008 American Heart Association, Inc. 2008 |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 8FD FR3 P64 RC3 7X8 5PM |
| DOI | 10.1161/HYPERTENSIONAHA.107.104273 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | Genetics Abstracts CrossRef Genetics Abstracts MEDLINE MEDLINE - Academic Genetics Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1524-4563 |
| EndPage | 365 |
| ExternalDocumentID | PMC2692710 18591461 20535818 10_1161_HYPERTENSIONAHA_107_104273 00004268-200808000-00033 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL074735 – fundername: NHLBI NIH HHS grantid: HL 74735 – fundername: NCATS NIH HHS grantid: UL1 TR000454 – fundername: NHLBI NIH HHS grantid: HL 53335 |
| GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 18M 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BCGUY BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YOC YYM YYP ZFV ZGI ZZMQN AAYXX ADGHP CITATION IQODW OZ- CGR CUY CVF ECM EIF NPM 8FD ADKSD FR3 P64 RC3 7X8 5PM |
| ID | FETCH-LOGICAL-c6993-b8ace2a569ae491b4d7bcef286e1261d50d9072880f75eeb8d914750a9b6a2d63 |
| ISSN | 0194-911X 1524-4563 |
| IngestDate | Thu Aug 21 14:30:26 EDT 2025 Fri Sep 05 10:21:53 EDT 2025 Mon Sep 08 12:05:02 EDT 2025 Thu Sep 04 18:21:28 EDT 2025 Mon Sep 08 04:24:25 EDT 2025 Mon Jul 21 05:36:23 EDT 2025 Mon Jul 21 09:13:01 EDT 2025 Tue Jul 01 04:30:46 EDT 2025 Thu Apr 24 23:11:28 EDT 2025 Fri May 16 03:51:29 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Diuretic Hypertension Pharmacogenetics Antihypertensive agent Chromosome Cardiovascular disease Arterial pressure Blood pressure Thiazide Genome Locus |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c6993-b8ace2a569ae491b4d7bcef286e1261d50d9072880f75eeb8d914750a9b6a2d63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.107.104273 |
| PMID | 18591461 |
| PQID | 19713577 |
| PQPubID | 23462 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2692710 proquest_miscellaneous_69354720 proquest_miscellaneous_20936339 proquest_miscellaneous_19927102 proquest_miscellaneous_19713577 pubmed_primary_18591461 pascalfrancis_primary_20535818 crossref_citationtrail_10_1161_HYPERTENSIONAHA_107_104273 crossref_primary_10_1161_HYPERTENSIONAHA_107_104273 wolterskluwer_health_00004268-200808000-00033 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2008-August |
| PublicationDateYYYYMMDD | 2008-08-01 |
| PublicationDate_xml | – month: 08 year: 2008 text: 2008-August |
| PublicationDecade | 2000 |
| PublicationPlace | Philadelphia, PA Hagerstown, MD |
| PublicationPlace_xml | – name: Philadelphia, PA – name: Hagerstown, MD – name: United States |
| PublicationTitle | Hypertension (Dallas, Tex. 1979) |
| PublicationTitleAlternate | Hypertension |
| PublicationYear | 2008 |
| Publisher | American Heart Association, Inc Lippincott |
| Publisher_xml | – name: American Heart Association, Inc – name: Lippincott |
| References | e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_20_2 e_1_3_2_10_2 e_1_3_2_21_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_22_2 e_1_3_2_4_2 e_1_3_2_12_2 (e_1_3_2_18_2) 1995; 12 e_1_3_2_23_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_24_2 e_1_3_2_2_2 e_1_3_2_14_2 |
| References_xml | – ident: e_1_3_2_7_2 doi: 10.1001/jama.280.13.1168 – ident: e_1_3_2_8_2 doi: 10.1161/01.hyp.0000186240.81996.57 – ident: e_1_3_2_15_2 doi: 10.1126/science.1105436 – ident: e_1_3_2_2_2 doi: 10.1097/00004872-200102000-00022 – ident: e_1_3_2_10_2 doi: 10.1046/j.1523-1755.2002.00200.x – ident: e_1_3_2_1_2 doi: 10.1161/hyp.34.3.466 – ident: e_1_3_2_13_2 doi: 10.1086/381000 – ident: e_1_3_2_6_2 doi: 10.1056/NEJM199304013281303 – ident: e_1_3_2_3_2 doi: 10.1161/01.hyp.12.3.223 – ident: e_1_3_2_11_2 doi: 10.1016/S0895-7061(03)01011-2 – ident: e_1_3_2_23_2 doi: 10.1073/pnas.0506580102 – ident: e_1_3_2_12_2 doi: 10.1101/gr.197201 – volume: 12 start-page: 921 year: 1995 ident: e_1_3_2_18_2 publication-title: Mol Biol Evol – ident: e_1_3_2_16_2 doi: 10.1038/ng1847 – ident: e_1_3_2_5_2 doi: 10.1161/01.HYP.0000107251.49515.c2 – ident: e_1_3_2_17_2 doi: 10.1159/000057986 – ident: e_1_3_2_20_2 doi: 10.1111/j.1524-6175.2002.00965.x – ident: e_1_3_2_21_2 doi: 10.1038/ng749 – ident: e_1_3_2_19_2 doi: 10.1086/338688 – ident: e_1_3_2_9_2 doi: 10.1016/S0140-6736(97)01029-5 – ident: e_1_3_2_14_2 doi: 10.1038/nature04226 – ident: e_1_3_2_22_2 doi: 10.1007/s00251-005-0025-x – ident: e_1_3_2_24_2 doi: 10.1371/journal.pbio.0020427 – ident: e_1_3_2_4_2 doi: 10.1161/HYPERTENSIONAHA.107.087049 |
| SSID | ssj0014447 |
| Score | 2.2726026 |
| Snippet | We conducted a genome-wide association study to identify novel genes influencing diastolic blood pressure (BP) response to hydrochlorothiazide, a commonly... |
| SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wolterskluwer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 359 |
| SubjectTerms | Adult Antihypertensive agents Arterial hypertension. Arterial hypotension Biological and medical sciences Black People - genetics Blood and lymphatic vessels Blood Pressure Determination Cardiology. Vascular system Cardiovascular system Case-Control Studies Chromosomes, Human, Pair 12 Female Follow-Up Studies Genetic Predisposition to Disease Genome Humans Hydrochlorothiazide - administration & dosage Hypertension - drug therapy Hypertension - epidemiology Hypertension - genetics Logistic Models Male Medical sciences Middle Aged Pharmacogenetics Pharmacology. Drug treatments Polymorphism, Genetic Probability Risk Assessment Treatment Outcome White People - genetics |
| Title | Genomic Association Analysis Suggests Chromosome 12 Locus Influencing Antihypertensive Response to Thiazide Diuretic |
| URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-200808000-00033 https://www.ncbi.nlm.nih.gov/pubmed/18591461 https://www.proquest.com/docview/19713577 https://www.proquest.com/docview/19927102 https://www.proquest.com/docview/20936339 https://www.proquest.com/docview/69354720 https://pubmed.ncbi.nlm.nih.gov/PMC2692710 |
| Volume | 52 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBDShLiOchl-4K1qqS-xk8cONirYJjQ6qTxFuTi0gjVTmwq0f8i_4hznUndb0cZLVMV2k_h89rn4XAh5m7HEHth1NWo60pdpN0pY1k1jLaXx8SwNTQNHx2p4Kj-NvXGr9cfxWloWcS-5uDau5H-oCveArhglewvKNn8KN-A30BeuQGG43ojGH40NKnbneJVl5OvyO54dLTB_QH6WL_Iz02G8c5gnywVsC2VtEmsUmRXTCaij89qZ_aT0m7VFNUaTaXQxTQ3sjUsb8OhKs8NmlMWQ_wGt8qXfkfnd67BAB46lYYTm07njWtYZ9VaG1GllPP-MzgknTcPBfJpWLXtzTA_aOWzanNiJwRy4p-ns9dasGH7jQ1c4gQMRZveC2XSn7YpLKMikErfosbuHe9zBKnc2ZFHlGy95uyjrUlxlGwrZxvDbl31QIo6Riw2Ggx5D4xvWIhErZtm4MFrliisLSMzNWQboC3GH3OUaxDiMOx833kagtsoqcr98-Sr_LTz43ebHrslK2-fRApZtVtZbuU4huurXu_0rR5-LxQ8bcuEITqOH5EGl8dBBCd9HpGVmj8m9o8qn4wkpKhRThxy0RjGtUUxXKKaMU4ti6qCYXkYxrVFMi5zWKKY1ip-S04P90ftht6oF0k0UupjGfoSl6zwVREYGLJapjhOTcV8ZxhVLvX4a9DUHbpRpz5jYTwMmQRqOglhFPFXiGdma5TPznFA_jRNfxCI1hsvE9_1MR0IpA_w2C7iM2iSoZz1MqkT5WK_lZ2gVZsXCSxSD-zosKdYmohl7XqaLudGo3TXiNkM5Zl8CkbpN3tTUDmH7xzO9aGby5SKElcyEp_W_egQc1YjNPXg_EEqIYHMPFQhPat5vk50SYauPw_yXUrE20WvYazpg-vr1ltl0YtPYc2VfrE26aygNywDwcNMCe3HL_i_J_dWG84psFfOleQ2KRBHv2iX6F5gtGoU |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genomic+Association+Analysis+Suggests+Chromosome+12+Locus+Influencing+Antihypertensive+Response+to+Thiazide+Diuretic&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Turner%2C+Stephen+T.&rft.au=Bailey%2C+Kent+R.&rft.au=Fridley%2C+Brooke+L.&rft.au=Chapman%2C+Arlene+B.&rft.date=2008-08-01&rft.pub=American+Heart+Association%2C+Inc&rft.issn=0194-911X&rft.volume=52&rft.issue=2&rft.spage=359&rft.epage=365&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.107.104273&rft.externalDocID=00004268-200808000-00033 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |